Syngene with an investment of US$9.5 (INR 788 crores) plans to build new state-of-the-art research laboratories in Hyderabad, India. This will be an extension to its existing research campus.
The expansion of operations in Genome Valley, includes the new research and development facility for the development of biotech industry.
The facility also houses a cutting-edge PROTAC laboratory dedicated to conducting advanced research on disease-causing proteins, which play a central role in illnesses like cancer. Additionally, there is a central compound management facility, serving as the central storage hub for all compounds synthesized by scientists.
The research conducted at the new facility with a primary focus on discovery chemistry and biology is pivotal for the advancement of the pharmaceutical industry. These areas are fundamental in drug discovery and development.
The facility will provide the essential infrastructure and support systems required to empower cutting-edge life science research and development (R&D) activities.
The new campus aims to generate up to 1000 science-related jobs within the next five years.
Construction of the new facilities is scheduled to commence in 2024.
Type New Construction
Budget US$9.5 (INR 788 crores)